Moderna Inc. said it would ask U.S. and European regulators Monday to allow emergency use of its COVID-19 vaccine as new study results confirm the shots offer strong protection — ramping up the race to begin limited vaccinations as the coronavirus rampage worsens. Multiple vaccine candidates must succeed for the world to stamp out the pandemic, which has been on the upswing in the U.S. and Europe. U.S. hospitals have been stretched to the limit as the nation has seen more than 160,000 new cases per day and more than 1,400 daily deaths.
WiSA’s first branded product, SoundSend audio transmitter, now available for WiSA partners, distributors and retailers
Mastercard, TSYS and Extend today introduced a mobile virtual corporate card solution to support for fast and secure contactless payments.
Oak Street Health Announces Participation at Piper Sandler 32nd Annual Virtual Healthcare Conference
Tecnológico de Monterrey has moved up 3 places in the rankings of top universities for entrepreneurship. In 6 years, it has gone from 23rd to 5th place in "The Princeton Review: Top Undergraduate Schools for Entrepreneurship Ranking 2021," published by The Princeton Review and Entrepreneur Magazine.
Angus Reid Institute and Clear Seas Centre study reveals what Canadians think about marine shipping and its role in post COVID-19 economic recovery.
Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) today announced the completion of its target enrollment in the INTRIGUE Phase 3 clinical study evaluating the efficacy and safety of QINLOCK in patients with second-line gastrointestinal stromal tumor (GIST). QINLOCK, the Company’s switch-control tyrosine kinase inhibitor, is currently approved in the U.S., Canada, and Australia for patients with fourth-line GIST.
Sherritt International Corporation ("Sherritt" or "the Corporation") (TSX:S), a world leader in the mining and refining of nickel and cobalt from lateritic ores, today announced that it has renewed and extended its $70 million credit facility with its syndicate of lenders to April 30, 2022. The renewal builds on the Corporation’s recently completed balance sheet initiative and related efforts to strengthen its capital structure and improve its liquidity.
On Tuesday, Dec. 1, Los Angeles’ top rated morning radio show, The Ellen K Morning Show on KOST 103.5, will help kick off the season of giving with the Children’s Hospital Los Angeles (CHLA) annual Giving Tuesday fundraising campaign. Giving Tuesday is the international day of charitable giving that takes place on the first Tuesday after Thanksgiving.
Verastem, Inc. (Nasdaq:VSTM) (also known as Verastem Oncology), a biopharmaceutical company committed to advancing new medicines for patients battling cancer, today announced the initiation of a Phase 2 registration-directed clinical trial of VS-6766, its RAF/MEK inhibitor, and defactinib, its FAK inhibitor, in patients with recurrent low-grade serous ovarian cancer (LGSOC).
PureTech to Host Virtual R&D Day for Investors on December 11, 2020
Kinaset Therapeutics, Inc. ("Kinaset" or the "Company"), a newly-founded biopharmaceutical company, today announced a $40 million Series A financing with a blue-chip investor syndicate of 5AM Ventures, Atlas Venture, and Gimv. The Company also announced an exclusive global in-license and services agreement with Vectura Group plc (LSE: VEC) ("Vectura") to develop and commercialize KN-002 (formerly known as VR588), a novel, inhaled small-molecule pan-JAK inhibitor, for the treatment of eosinophilic and non-eosinophilic severe asthma. A Phase 1/1b clinical trial in healthy volunteers and patients is poised to begin in the first half of 2021.
Warrior Gold Inc. (TSX-V - WAR) ("Warrior Gold" or the "Company") is pleased to announce a non-brokered private placement to raise up to $1 million through the issuance of a combination of common share units (the "HD Units") and flow-through share units (the "FT Units") of the Company at a price of $0.09 per HD Unit and $0.12 per FT Unit (the "Private Placement"). Each Unit will comprise one common share, and in the case of the FT Units, one flow-through share, and one-half of one common share purchase warrant (each whole common share purchase warrant, a "Warrant") with each Warrant entitling the holder to purchase one additional common share in the capital of the Company for a period of 18 months from the date of closing of the Private Placement, at a purchase price of $0.15 per common share, provided, however, that, if, at any time following the statutory four month hold period, the closing price of the common shares on the TSX Venture Exchange is greater than $0.20 for 20 or more consecutive trading days, the Warrants will be accelerated and will expire on the 30th business day following the date of such notice.
NeoImmuneTech announces the first patient dosed in a Phase 1 study of NT-I7 in adults with mild COVID-19.
Antibe Therapeutics Announces TSX Approval and Effective Date of Share Consolidation
Piper Sandler Expands Public Finance Investment Banking with the Addition of Special District Group
Aggressor Adventures®, a leading adventure travel brand, today announces it will expand its adventure offerings with the addition of a bucket list adventure exploring southern Costa Rica with Les Stroud. The new trip explores the "crown jewel" of Costa Rica’s national parks, Corcovado National Park, which is often hailed as one of the most diverse ecosystems in the world
Moderna announces primary efficacy analysis in Phase 3 COVE study for Its COVID-19 vaccine candidate.
Citizens Financial Group, Inc. (NYSE: CFG) today announced the appointment of Christopher (Chris) J. Swift and Lee Alexander to its board of directors, effective February 1, 2021. Mr. Swift currently serves as Chairman and Chief Executive Officer of The Hartford Financial Services Group, a national leader in property and casualty insurance, group benefits and mutual funds, founded in 1810. Mr. Alexander is the Executive Vice President and Chief Information Officer for The Clearing House, operator of core payments system infrastructure in the United States, including a real-time payment system. Mr. Swift will serve on the board's Risk Committee, and Mr. Alexander will serve on the board’s Audit Committee.
Summary “Asia - Pacific Electrophysiology Procedures Outlook to 2025” is a comprehensive databook report, covering key procedures data on the Asia - Pacific Electrophysiology Procedures.New York, Nov. 30, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Asia-Pacific Electrophysiology Procedures Outlook to 2025 - Electrophysiology Diagnostic Catheters Procedures and Electrophysiology Ablation Catheters Procedures" - https://www.reportlinker.com/p05993106/?utm_source=GNW The databook report provides procedure volumes within segments - Electrophysiology Diagnostic Catheters Procedures and Electrophysiology Ablation Catheters Procedures. The Asia - Pacific Electrophysiology Procedures report provides key information and data on - \- Procedure volume data for Electrophysiology Procedures related to the country. Data is provided from 2015 to 2025. Scope Asia - Pacific Electrophysiology Procedures is segmented as follows - \- Electrophysiology Diagnostic Catheters Procedures \- Electrophysiology Ablation Catheters Procedures Reasons to Buy The Asia - Pacific Electrophysiology Procedures report helps you to develop - \- Business strategies by identifying the key segments poised for strong growth in the future. \- Market-entry and market expansion strategies. \- Develop investment strategies by identifying the key segments expected to register strong growth in the near future. Read the full report: https://www.reportlinker.com/p05993106/?utm_source=GNW About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________ CONTACT: Clare: email@example.com US: (339)-368-6001 Intl: +1 339-368-6001